Literature DB >> 25267539

The potential value of comprehensive geriatric assessment in evaluating older women with primary operable breast cancer undergoing surgery or non-operative treatment--a pilot study.

Ruth M Parks1, Louise Hall1, Siau-Wei Tang1, Penny Howard2, Radhika Lakshmanan1, Linda Winterbottom3, David A Morgan4, Davina Porock5, Karen Cox2, Kwok-Leung Cheung6.   

Abstract

OBJECTIVES: Breast cancer in older women raises a number of discrete issues, including how healthcare professionals can best decide which patients are candidates for surgery. A pilot study involving women aged ≥70years newly diagnosed with early operable primary breast cancer was conducted aiming to explore the potential value of comprehensive geriatric assessment (CGA).
MATERIALS AND METHODS: Decision of primary treatment followed consultation with the clinical team and was not guided by any aspect of this study. CGA, using a validated cancer-specific tool, was conducted within 6weeks and 6months after diagnosis, complemented by formal measures of quality of life (QOL) (using EORTC QLQ-C30 and QLQ-BR23) and semi-structured interviews. A total of 47 female patients with a new diagnosis of clinically early (stage 1 or 2; cT0-2N0-1M0) operable primary breast cancer proven histologically, were recruited.
RESULTS: CGA determined that increasing age (≥80years) (p=0.001), greater (≥4) comorbidity (p=0.022), greater number (≥4) of daily medications (p=0.002), and slower (≥19s) timed up and go (TUG) (p=0.016) score were significantly related to non-surgical treatment at 6weeks after diagnosis. Baseline QOL scores were generally good and they remained stable at 6months follow-up. As opposed to CGA, there was no correlation between QOL scores and the treatment modality identified. Semi-structured interviews identified themes consistent with findings from QOL assessment.
CONCLUSION: The pilot study confirmed the feasibility of conducting CGA in a research setting which appeared to have value in assessing this patient population. More data will be required to definitively identify the components for geriatric assessment in this setting. The study has now extended into two more centres.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CGA; Comprehensive geriatric assessment; Non-surgery; Primary endocrine therapy; Primary operable breast cancer; Quality of life; Surgery

Mesh:

Year:  2014        PMID: 25267539     DOI: 10.1016/j.jgo.2014.09.180

Source DB:  PubMed          Journal:  J Geriatr Oncol        ISSN: 1879-4068            Impact factor:   3.599


  5 in total

Review 1.  Polypharmacy and potentially inappropriate medication use in geriatric oncology.

Authors:  Manvi Sharma; Kah Poh Loh; Ginah Nightingale; Supriya G Mohile; Holly M Holmes
Journal:  J Geriatr Oncol       Date:  2016-08-03       Impact factor: 3.599

Review 2.  Surgery in the Older Patient with Breast Cancer.

Authors:  Julia Frebault; Carmen Bergom; Amanda L Kong
Journal:  Curr Oncol Rep       Date:  2019-06-25       Impact factor: 5.075

3.  Associations of Polypharmacy and Inappropriate Medications with Adverse Outcomes in Older Adults with Cancer: A Systematic Review and Meta-Analysis.

Authors:  Mostafa R Mohamed; Erika Ramsdale; Kah Poh Loh; Asad Arastu; Huiwen Xu; Spencer Obrecht; Daniel Castillo; Manvi Sharma; Holly M Holmes; Ginah Nightingale; Katherine M Juba; Supriya G Mohile
Journal:  Oncologist       Date:  2019-09-30

4.  Impact of Treatment Type on Overall Survival in ElderlyBrazilian Women with Breast Cancer

Authors:  Marcelo Adeodato Bello; Raquel Ferreira de Menezes; Brunna Silva; Rafael de Carvalho da Silva; Rousiane Silva Cavalcanti; Thayane de Fátima da Costa Moraes; Fabiana Tonellotto; Suzana Sales de Aguiar; Renata Brum Martucci; Anke Bergmann; Luiz Claudio Thuler
Journal:  Asian Pac J Cancer Prev       Date:  2016-10-01

5.  The Charlson Comorbidity Index and depression are associated with satisfaction after short-segment lumbar fusion in patients 75 years and older.

Authors:  Shuai-Kang Wang; Hong Mu; Peng Wang; Xiang-Yu Li; Chao Kong; Jing-Bo Cheng; Shi-Bao Lu; Guo-Guang Zhao
Journal:  Front Surg       Date:  2022-09-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.